Table 3 Criteria for the identification of health technology reassessment in the main countries reviewed

Identification

Selection criteria for medical technologies evaluation in NICE

- Claimed additional benefit to patients

- Claimed healthcare system benefit

- Patient population

- Disease impact

- Cost considerations

- Sustainability

- New evidence (safety, effectiveness)

- Geographic variations in care

- Provider variations in care (clinical heterogeneity)

- Temporal variations in volume (a trend in item volume between time points)

- Technology development

- Public interest or controversy

- Consultation

- Nomination

- Assess new intervention, displace old

- Leakage

- Legacy items

- Conflict with guidelines

- Precedent

- New evidence (safety, effectiveness)

- Geographic variations in care

- Provider variations in care (clinical heterogeneity)

- Temporal variations in volume (a trend in item volume between time points)

- Technology development

- Public interest or controversy

- Consultation

- Nomination

- Assess new intervention, displace old

- Leakage

- Legacy items

- Conflict with guidelines

Guideline for Not Funding existing health Technologies in healthcare systems

- Technology to be used in the centre or place

- Technology status known to the applicant

- Alternative treatment option available

- No absence of care with disinvestment

Detection criteria

- Is currently used (health services portfolio)

- Alternative technologies are available